Treatment of neurological disorders by dsRNA administration
US8129354B2 · kind B2 · utility
1Cited by
4References
25Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 17, 2007 |
| Grant date | Mar 6, 2012 |
| Priority date | — |
| Expiry date | Mar 16, 2028 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2310/335
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to methods to treat neurological disorders comprising intrathecal injection of an effective amount of a double-stranded (ds) RNA into a subject in need, wherein the dsRNA inhibits the expression of a target gene and to pharmaceutical compositions useful for such treatment.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.